-
1
EML4‐ALK‐Positive Ovarian Cancer With Intracranial Metastasis Responds to Lorlatinib: A Case Report and Literature Review
Published 2025-01-01Subjects: Get full text
Article -
2
Long term efficacy and safety of Lorlatinib in ALK-positive non-small cell lung cancer: A case report
Published 2025-03-01Subjects: Get full text
Article